Senate panel opens inquiry into EpiPen pricing

WASHINGTON (AP) " A Senate panel has opened a preliminary investigation into why the price of lifesaving EpiPens has skyrocketed.

The top Republican and Democrat on the Senate Homeland's investigations subcommittee said in a statement Wednesday that they began an inquiry into Mylan Pharmaceuticals' pricing and competition practices. Mylan has been sharply criticized for its steep price increases for the emergency allergy treatment EpiPen.

The price has grown to $608 for a two-pack, up more than 500 percent since 2007. The drugmaker has announced it will launch a generic version that will cost $300 in the next several weeks.

GOP Sen. Rob Portman of Ohio and Democratic Sen. Claire McCaskill of Missouri head the panel.

Heather Bresch, CEO of the pharmaceutical company, is the daughter of Democratic Sen. Joe Manchin of West Virginia.

This story has been automatically published from the Associated Press wire which uses US spellings

Get the news delivered straight to your inbox

Receive the day’s news, sport and entertainment in our daily email newsletter


© Copyright 2016, NZME. Publishing Limited

Assembled by: (static) on production bpcf04 at 23 Oct 2016 08:48:22 Processing Time: 514ms